Best Hiring Practice For Fast-Growth BioTech | Dr. Chris Winrow

‘I think an appreciation for translational research has really started to emerge over the past few years.’ Dr Chris Winrow has had an excellent vantage point from which to observe how approaches to translational research have changed in recent years. An expert in neurodegenerative disease, with over 20 years’ experience in pharma and biotech in a variety of research, translational, and clinical roles, he joined Lucy Therapeutics as CSO in March 2023. Paula Doust Alba, our CNS & Rare Disease Consultant, welcomed Chris to an episode of the Venari Podcast’s R&D Hiring Strategy series to discuss his career, his thoughts on team building, what he looks for in new hires, and the future of translational research.